BCL2 and acute myeloid leukemia: As a specific Bcl-2 inhibitor, venetoclax effectively induces apoptosis in vitro in cancer cells that overexpress Bcl-2.[85] In a time- and concentration-dependent way, Yuan et al found that venetoclax and HHT worked in concert to suppress AML growth, lower mitochondrial membrane potential, and accelerate AML cell death.